Cargando…
Cost effectiveness analysis of implementing tuberculosis screening among applicants for non-immigrant U.S. work visas
BACKGROUND: While persons who receive immigrant and refugee visas are screened for active tuberculosis before admission into the United States, nonimmigrant visa applicants (NIVs) are not routinely screened and may enter the United States with infectious tuberculosis. OBJECTIVES: We evaluated the co...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761151/ https://www.ncbi.nlm.nih.gov/pubmed/33357237 http://dx.doi.org/10.1186/s41479-020-00078-z |
_version_ | 1783627501585563648 |
---|---|
author | Sayed, Bisma Ali Posey, Drew L. Maskery, Brian Wingate, La’Marcus T. Cetron, Martin S. |
author_facet | Sayed, Bisma Ali Posey, Drew L. Maskery, Brian Wingate, La’Marcus T. Cetron, Martin S. |
author_sort | Sayed, Bisma Ali |
collection | PubMed |
description | BACKGROUND: While persons who receive immigrant and refugee visas are screened for active tuberculosis before admission into the United States, nonimmigrant visa applicants (NIVs) are not routinely screened and may enter the United States with infectious tuberculosis. OBJECTIVES: We evaluated the costs and benefits of expanding pre-departure tuberculosis screening requirements to a subset of NIVs who arrive from a moderate (Mexico) or high (India) incidence tuberculosis country with temporary work visas. METHODS: We developed a decision tree model to evaluate the program costs and estimate the numbers of active tuberculosis cases that may be diagnosed in the United States in two scenarios: 1) “Screening”: screening and treatment for tuberculosis among NIVs in their home country with recommended U.S. follow-up for NIVs at elevated risk of active tuberculosis; and, 2) “No Screening” in their home country so that cases would be diagnosed passively and treatment occurs after entry into the United States. Costs were assessed from multiple perspectives, including multinational and U.S.-only perspectives. RESULTS: Under “Screening” versus “No Screening”, an estimated 179 active tuberculosis cases and 119 hospitalizations would be averted in the United States annually via predeparture treatment. From the U.S.-only perspective, this program would result in annual net cost savings of about $3.75 million. However, rom the multinational perspective, the screening program would cost $151,388 per U.S. case averted for Indian NIVs and $221,088 per U.S. case averted for Mexican NIVs. CONCLUSION: From the U.S.-only perspective, the screening program would result in substantial cost savings in the form of reduced treatment and hospitalization costs. NIVs would incur increased pre-departure screening and treatment costs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41479-020-00078-z. |
format | Online Article Text |
id | pubmed-7761151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77611512020-12-28 Cost effectiveness analysis of implementing tuberculosis screening among applicants for non-immigrant U.S. work visas Sayed, Bisma Ali Posey, Drew L. Maskery, Brian Wingate, La’Marcus T. Cetron, Martin S. Pneumonia (Nathan) Research BACKGROUND: While persons who receive immigrant and refugee visas are screened for active tuberculosis before admission into the United States, nonimmigrant visa applicants (NIVs) are not routinely screened and may enter the United States with infectious tuberculosis. OBJECTIVES: We evaluated the costs and benefits of expanding pre-departure tuberculosis screening requirements to a subset of NIVs who arrive from a moderate (Mexico) or high (India) incidence tuberculosis country with temporary work visas. METHODS: We developed a decision tree model to evaluate the program costs and estimate the numbers of active tuberculosis cases that may be diagnosed in the United States in two scenarios: 1) “Screening”: screening and treatment for tuberculosis among NIVs in their home country with recommended U.S. follow-up for NIVs at elevated risk of active tuberculosis; and, 2) “No Screening” in their home country so that cases would be diagnosed passively and treatment occurs after entry into the United States. Costs were assessed from multiple perspectives, including multinational and U.S.-only perspectives. RESULTS: Under “Screening” versus “No Screening”, an estimated 179 active tuberculosis cases and 119 hospitalizations would be averted in the United States annually via predeparture treatment. From the U.S.-only perspective, this program would result in annual net cost savings of about $3.75 million. However, rom the multinational perspective, the screening program would cost $151,388 per U.S. case averted for Indian NIVs and $221,088 per U.S. case averted for Mexican NIVs. CONCLUSION: From the U.S.-only perspective, the screening program would result in substantial cost savings in the form of reduced treatment and hospitalization costs. NIVs would incur increased pre-departure screening and treatment costs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41479-020-00078-z. BioMed Central 2020-12-25 /pmc/articles/PMC7761151/ /pubmed/33357237 http://dx.doi.org/10.1186/s41479-020-00078-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Sayed, Bisma Ali Posey, Drew L. Maskery, Brian Wingate, La’Marcus T. Cetron, Martin S. Cost effectiveness analysis of implementing tuberculosis screening among applicants for non-immigrant U.S. work visas |
title | Cost effectiveness analysis of implementing tuberculosis screening among applicants for non-immigrant U.S. work visas |
title_full | Cost effectiveness analysis of implementing tuberculosis screening among applicants for non-immigrant U.S. work visas |
title_fullStr | Cost effectiveness analysis of implementing tuberculosis screening among applicants for non-immigrant U.S. work visas |
title_full_unstemmed | Cost effectiveness analysis of implementing tuberculosis screening among applicants for non-immigrant U.S. work visas |
title_short | Cost effectiveness analysis of implementing tuberculosis screening among applicants for non-immigrant U.S. work visas |
title_sort | cost effectiveness analysis of implementing tuberculosis screening among applicants for non-immigrant u.s. work visas |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761151/ https://www.ncbi.nlm.nih.gov/pubmed/33357237 http://dx.doi.org/10.1186/s41479-020-00078-z |
work_keys_str_mv | AT sayedbismaali costeffectivenessanalysisofimplementingtuberculosisscreeningamongapplicantsfornonimmigrantusworkvisas AT poseydrewl costeffectivenessanalysisofimplementingtuberculosisscreeningamongapplicantsfornonimmigrantusworkvisas AT maskerybrian costeffectivenessanalysisofimplementingtuberculosisscreeningamongapplicantsfornonimmigrantusworkvisas AT wingatelamarcust costeffectivenessanalysisofimplementingtuberculosisscreeningamongapplicantsfornonimmigrantusworkvisas AT cetronmartins costeffectivenessanalysisofimplementingtuberculosisscreeningamongapplicantsfornonimmigrantusworkvisas |